Clinical Trials on CLL, Relapsed

Total 436195 results

National Institute on Drug Abuse (NIDA)

Terminated

Pioglitazone to Treat Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Stress and Medication Effects on Cocaine Cue Reactivity

Cocaine Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Abuse Potential of Buprenorphine/Naloxone

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Tramadol to Reduce Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Interactions Between Intravenous (IV) Cocaine and Lofexidine

Cocaine Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Opioid-Related Disorders

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Long-term Behavior Change - 1

Amphetamine-related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 1 - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Opioid-Related Disorders

United States
Indivior Inc.

Completed

Safety and Tolerability of Buprenorphine/Naloxone Film Strips

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

FMRI of Stress and Addictive Disorders

Alcoholism | Opioid Dependence | Cocaine Dependence | Adolescents | Pathological Gamblers

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA); University of Texas

Terminated

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

Opiate Dependence | Cocaine Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

Opioid Dependence | Cocaine Abuse
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Heroin Dependence | Cocaine-Related Disorders

United States
Universiti Sains Malaysia
Yale University

Unknown

An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence

Heroin Dependence | Amphetamine Dependence

Malaysia
Universiti Sains Malaysia
Yale University

Unknown

An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence

Heroin Dependence | Amphetamine Dependence

Malaysia
Adrienne Sabety
Ohio State University; Ohio Recovery Housing

Not yet recruiting

Housing for Recovery Initiative

Substance-related Disorders | Alcohol-related Disorders | Housing
Indivior Inc.

Completed

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)

Drug Abuse | Opiate Dependence | Opiate-related Disorders
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Cocaine Withdrawal and Pharmacotherapy Response (Carvedilol)

Cocaine Dependence | Opiate Dependence

United States
Prof. Dominique de Quervain, MD
Psychiatric Hospital of the University of Basel

Terminated

Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants (Goliath)

Opioid Dependence | Cocaine Dependence

Switzerland
Baylor College of Medicine
National Institute on Drug Abuse (NIDA); Yale University

Completed

Pharmacogenetics of Disulfiram for Cocaine (Disulfiram)

Opioid Dependence | Cocaine Dependence

United States
Yale University

Completed

Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. (Keppra)

Opioid Dependence | Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Heroin Dependence | Cocaine-Related Disorders

United States
Philogen S.p.A.

Terminated

A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia, Relapsed, Adult

Germany
Inventage Lab., Inc.

Not yet recruiting

A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3004

Alcohol Dependence | Opioid Dependence
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy (STEPuP)

Pregnancy Related | Opioid-use Disorder

United States
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention

Completed

De-prescribing Program to Evaluate Falls in Older Adults

Opioid-Related Disorders | Benzodiazepine-Related Disorders | Falls Injury

United States
Baylor College of Medicine
Cancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaborators

Active, not recruiting

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Refractory Neuroblastoma | Uveal Melanoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma | Relapsed Neuroblastoma | Relapsed Rhabdomyosarcoma | Phyllodes Breast Tumor

United States
Washington University School of Medicine

Recruiting

Improving Health and Employment Outcomes Through Workplace Opioid Policies

Opioid-Related Disorders

United States
Biomedical Development Corporation
National Institute on Drug Abuse (NIDA); The University of Texas Health Science...

Active, not recruiting

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder (KIOS-I)

Opioid-Related Disorders

United States
Karlstad Central Hospital

Completed

Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.

Opioid-Related Disorders

Sweden
Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS)

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Maryland, Baltimore

Completed

Youth Opioid Recovery Support: Improving Care Systems (YORS)

Opioid-Related Disorders

United States
Duke University
Alkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaborators

Completed

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings (DC)

Opioid-Related Disorders

United States
Roxane Laboratories

Completed

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Opioid-Related Disorders

United States

Clinical Trials on CLL, Relapsed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations